MAMMO-MED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

TAX ID9571020331

KRS0000329768

Share capital50,000.00 zł

★ ★ ★ ★ ★ ★ ★ ★ ★ ★

No opinion. Add your first review

address

AL. GRUNWALDZKA 56, 80-241 GDAŃSK

Show on map

Is this your company?Update company information to get new customers, get notified of new reviews, and more!

Register Data

Full name

MAMMO-MED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

uses securityreCAPTCHA

Privacy – Terms of Use

Legal address

AL. GRUNWALDZKA 56, 80-241 GDAŃSK

Show on map

NIP

9571020331

REGON

220796810

KRS

0000329768

Legal form

limited liability company

Register Address

AL. GRUNWALDZKA 56, 80-241 GDAŃSK

Date of registration in KRS

2009-05-19

Date of commencement of economic activity

2009-05-19

Act signature

RDF/602399/24/442

Pkd codes

86.22.Z - Specialist medical practice activities

21.10.Z - Manufacture of basic pharmaceutical substances

21.20.Z - Manufacture of medicines and other pharmaceutical products

32.50.Z - Manufacture of medical and dental instruments and supplies

46.46.Z - Wholesale of pharmaceutical goods

47.73.Z - Dispensing chemist in specialised stores

72.19.Z - Other research and experimental development on natural sciences and engineering

86.21.Z - General medical practice activities

86.90.A - Physiotherapeutical activities

86.90.C - Nurses and midwives activities

Payer VAT status

Active

Vat list bank account(s)

PL51 1090 1434 0000 0001 3502 1710

PL22 1560 0013 0000 1150 0009 0503

Company authorities

representation authorityMANAGEMENT

representation type

PREZES ZARZĄDU SAMODZIELNIE LUB ŁĄCZNIE DWÓCH CZŁONKÓW ZARZĄDU ALBO JEDEN CZŁONEK ZARZĄDU ŁACZNIE Z PROKURENTEM.

MANAGEMENT

Magdalena Maćkowiak

President Of The Company's Management, 43 years old

shareholders

Magdalena Maćkowiak

490 udziałów o łącznej wartości 49.000,00 złotych

Financial data

Net sales [PLN]

Gross profit / loss [PLN]

Automatically generated based on financial statements from KRS Registry

	2021	2022	2023
	M PLN	M PLN	M PLN	%
Profit (loss) on sale	0,4	0,1	1,4	2268,5
Gross profit (loss)	0,7	0,8	2,2	172,1
EBITDA	1	1,6	3,4	109,3
Short time liabilities	0,4	0,2	0,4	109,5
Other operating costs	0,2	0	0,1	320,7
Equity capital	1,1	1,1	2,4	112,1
Operating profit (EBIT)	0,7	0,8	2,2	171,8
Assets	3	4,9	5,4	8,4
Net profit (loss)	0,7	0,7	2	175,3
Cash	0,3	0,2	1	396
Liabilities and provisions for liabilities	1,9	3,8	3	-22
Net income from sale	5,2	5,9	8,9	50,1
Working assets	1,5	1,2	2,6	123,3
Other income costs	0,6	0,8	1	23,2
Depreciation	0,3	0,8	1,2	47,9
	%	%	%	p.p.
Profitability of capital	63,3	63,9	83	19,1
Equity capital to total assets	36,8	22,6	44,3	21,7
Gross profit margin	14,4	13,5	24,5	11
EBITDA Margin	19,6	27,4	38,2	10,8
	Days	Days	Days	Days
Short term commitment turnover cycle	25	12	16	4

Current financial liquidity indicator	4.089372158050537	6.265320301055908	6.677069664001465	0,4
Net dept to EBITDA	0.2053358256816864	0.009292872622609138	-0.26886117458343506	-0,3